Description

Ursohepavin (L-carnitine,ursodeoxycholic acid) capsules 510 mg. №30

Ingredients

Each capsule contains: L-carnitine 300 mg, ursodeoxycholic acid 210 mg.

Dosage

Recommended dosage: Take 1 capsule orally twice a day with meals.

Indications

Ursohepavin capsules are indicated for the treatment of liver disorders, including primary biliary cirrhosis and chronic hepatitis.

Contraindications

Do not use Ursohepavin capsules if: allergic to any of the ingredients, pregnant, or breastfeeding without medical advice.

Directions

Follow the instructions provided by your healthcare provider. Do not exceed the recommended dosage.

Scientific Evidence

Ursohepavin capsules have shown significant efficacy in improving liver function and reducing liver enzymes in patients with liver diseases. Studies have demonstrated the hepatoprotective effects of ursodeoxycholic acid and the role of L-carnitine in enhancing mitochondrial function, which is crucial for liver health.

Additional Information

Ursohepavin capsules are well-tolerated with minimal side effects reported. It is important to consult a healthcare professional before starting any new medication, especially if you have underlying medical conditions or are taking other medications concurrently.

The combination of L-carnitine and ursodeoxycholic acid in Ursohepavin capsules offers a synergistic effect in promoting liver health. L-carnitine plays a key role in fatty acid metabolism, while ursodeoxycholic acid has been shown to have anti-inflammatory and cytoprotective properties in the liver.